Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session
This article was originally published in The Gray Sheet
Executive Summary
Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.
You may also be interested in...
Industry Efforts Against Device Tax Haven't Slowed Down, Despite Suspension
The long-game effort by industry advocates to achieve permanent repeal of the device excise tax has switched from quantifying the detrimental impacts of the tax to spotlighting the positive outcomes from the recently enacted two-year suspension of the tax.
PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
PhRMA CEO: Ubl Pick Would Bring User Fee, Reimbursement Expertise
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.